Interaction of the chemokine receptors CXCR4 with β-arrestin 2 enhances stromal cell-derived factor 1α-induced activation of p38 MAPK and ERK, thereby augmenting lymphocyte and breast cancer chemotaxis [79]. The gene discussed is CXCR4; the disease is breast carcinoma.